Abstract

The present disclosure relates to a novel Bacillus velezensis strain and a method for preventing, treating, or improving tuberculosis comprising the same. More specifically, the present disclosure relates to a Bacillus velezensis PMC 206 strain extracted from vinegar and a use thereof, for example, an antibacterial composition having antibacterial activity against bacteria belonging to the genus Mycobacterium, a pharmaceutical composition or food composition for improving, treating, or preventing tuberculosis having antibacterial activity against bacteria belonging to the genus Mycobacterium.

IPC Classes  ?

• A61K 35/742 - Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• A61P 31/06 - Antibacterial agents for tuberculosis

Abstract

A method of predicting crash performance based on deep learning from vehicle crash acceleration data includes performing, by an input unit, wavelet transform on vehicle crash acceleration data. The method also includes applying wavelet transform data to a pre-trained model. The method also includes concatenating a feature extracted from the pre-trained model with a vehicle crash performance index. The method also includes calculating a crash prediction result in a crash performance model through artificial neural network learning from concatenated data of the vehicle crash performance index and the extracted feature.

IPC Classes  ?

• G06V 10/52 - Scale-space analysis, e.g. wavelet analysis
• G06V 10/44 - Local feature extraction by analysis of parts of the pattern, e.g. by detecting edges, contours, loops, corners, strokes or intersectionsConnectivity analysis, e.g. of connected components
• G06V 10/56 - Extraction of image or video features relating to colour
• G06V 20/70 - Labelling scene content, e.g. deriving syntactic or semantic representations

Abstract

The present disclosure relates to a method and device for providing a diagnosis result for nocturia diseases in a non-face-to-face manner. Provided according to an embodiment of the present disclosure is a method for providing a diagnosis result for nocturia disease in a non-face-to-face manner, the method comprising: performing a first test for determining the risk of developing a nocturia-related disease on the basis of basic health information of a user; performing a second test for diagnosing a nocturia disease if the first test result is normal; providing a diagnostic result, on the basis of results of the second test, for at least one of nocturnal polyuria (NP), lower urinary tract symptom (LUTS), overactive bladder (OAB), obstructive sleep apnea (OSA), and sleep disorders; and classifying treatment groups according to the severity of nocturia symptoms on the basis of the diagnostic results and basic health information.

IPC Classes  ?

• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
• G16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
• A61B 5/20 - Measuring urological functions
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61B 5/16 - Devices for psychotechnicsTesting reaction times
• A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
• G16H 20/70 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training

Abstract

The present disclosure relates to a method and device for presenting a treatment plan for nocturia disease in a non-face-to-face manner. Provided according to one embodiment of the present disclosure is a method for presenting a treatment plan for a nocturia disease in a non-face-to-face manner, the method comprising the steps of: obtaining diagnostic results for at least one condition among lower urinary tract symptoms (LUTS), overactive bladder (OAB), nocturnal polyuria (NP), obstructive sleep apnea (OSA), and sleep disorders for a user; determining a treatment group for the user's nocturia disease on the basis of the diagnostic results; generating a treatment plan for the determined treatment group; and presenting the treatment plan to the user through a user terminal to address the user's nocturia disease, wherein the treatment plan may include at least one of a first treatment plan for exercise, a second treatment plan for dietary control, a third treatment plan for sleep, and a fourth treatment plan for medication.

IPC Classes  ?

• G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
• G16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
• A61B 5/20 - Measuring urological functions
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61B 5/103 - Measuring devices for testing the shape, pattern, size or movement of the body or parts thereof, for diagnostic purposes
• G16H 20/70 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training

Abstract

The present invention relates to a method and system for collaborative parking and stopping reporting, the method, performed by a parking and stopping reading device, comprising the steps of: receiving a photographing time, a vehicle location, and vehicle license plate information on a first reported driving image from a first user terminal; receiving GPS information and wireless communication base station information and identifying the location of a vehicle; determining whether the vehicle is illegally parked or stopped by means of comparison with an illegal parking and stopping area DB; receiving, from second, third, … and nth user terminals, a photographing time, a vehicle location, and vehicle license plate information on second, third, … and nth reported driving images; determining a terminal capable of reporting illegal parking and stopping on the basis of a time difference between the first photographing time of the first reported driving image and the photographing times of the second, third, … and nth reported driving images; and manually or automatically reporting illegal parking and stopping in the terminal set as the terminal capable of reporting illegal parking and stopping.

IPC Classes  ?

• G06Q 50/26 - Government or public services
• G06Q 50/22 - Social work or social welfare, e.g. community support activities or counselling services
• G06V 20/62 - Text, e.g. of license plates, overlay texts or captions on TV images
• G06V 30/224 - Character recognition characterised by the type of writing of printed characters having additional code marks or containing code marks
• G06V 20/54 - Surveillance or monitoring of activities, e.g. for recognising suspicious objects of traffic, e.g. cars on the road, trains or boats
• G08G 1/017 - Detecting movement of traffic to be counted or controlled identifying vehicles

Abstract

The present application relates to a near-infrared ray absorption and emission complex comprising a carbazole-based donor and an acceptor.

IPC Classes  ?

• C09K 11/06 - Luminescent, e.g. electroluminescent, chemiluminescent, materials containing organic luminescent materials
• H10K 85/60 - Organic compounds having low molecular weight

Abstract

Disclosed are a system for a blockchain-based certificate and software stored in a computer-readable storage medium for operation thereof. The system comprises: an issuer device that issues, to a user terminal, a certificate including a digital signature of an issuer in response to a certificate issuance request from user terminal, and stores, in off-chain, information associated with issuance of certificate, the certificate issuance request including first public key of user and personal information of user, and the information associated with issuance of certificate including user's first public key, the user's personal information, and second public key of issuer; user terminal that provides service provider terminal with certificate including digital signature of user via wireless communication to receive verification of certificate; and service provider terminal that verifies certificate via on-chain, wherein at least some of information associated with issuance of certificate, stored in off-chain, is synchronized and stored in on-chain.

IPC Classes  ?

• H04L 9/32 - Arrangements for secret or secure communicationsNetwork security protocols including means for verifying the identity or authority of a user of the system
• H04L 9/08 - Key distribution

Abstract

The present invention relates to a composition for promoting the migration of adult stem cells, including miR-29a or miR-30c as an active ingredient, miR-29a or miR-30c, and a method for promoting the migration of adult stem cells, and it has been confirmed that the overexpression of miR-29a or miR-30c restores polarity, forms normal focal adhesions, and restores actomyosin-dependent contractile and traction forces, thereby promoting the migration of stem cells.

IPC Classes  ?

• A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
• C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Abstract

An inkjet printing system includes: an inkjet head unit including a nozzle for discharging ink, a driving unit for generating and outputting a driving voltage for discharging the ink from the nozzle, a first impedance adjusting unit disposed between an input terminal of the inkjet head unit and an output terminal of the driving unit and including a diode, and a self-sensing circuit unit that is connected to the input terminal of the inkjet head unit and receives a self-sensing voltage from the nozzle to determine whether the nozzle is operating normally.

IPC Classes  ?

• B41J 2/045 - Ink jet characterised by the jet generation process generating single droplets or particles on demand by pressure, e.g. electromechanical transducers

Abstract

Limosillactobacillus reuteriWeissella cibariaWeissella cibaria, or mixed strains including Lymosillactobacillus reuteri and Weissella cibaria, a culture thereof, a pharmaceutical composition for preventing or treating osteoporosis, and a health functional food composition for preventing or improving osteoporosis, each comprising same as an active ingredient.

IPC Classes  ?

• C12N 1/20 - BacteriaCulture media therefor
• A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
• A61P 19/10 - Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• C12R 1/01 - Bacteria or actinomycetales

Abstract

Disclosed is a mobile negative pressure chamber, that includes a bed, a main cover separably coupled to the bed, and having a main cavity, an auxiliary cover coupled to one side of the bed to be separable, that seals the main cavity while being engaged with the main cover, and having an auxiliary cavity, in which a lower body of the surgical recipient is located in an interior thereof, a main treatment part provided in at least one of the main cover and the auxiliary cover, and provided with a glove mounted on an arm of the surgical operator, and an auxiliary treatment part provided in at least one of the main cover and the auxiliary cover, and into and from which the arm of the surgical operator or a medical instrument is inserted and extracted.

IPC Classes  ?

• A61G 10/00 - Treatment rooms for medical purposes
• A61G 10/02 - Treatment rooms for medical purposes with artificial climateTreatment rooms for medical purposes with means to maintain a desired pressure, e.g. for germ-free rooms

Abstract

The present invention relates to a biomarker composition for diagnosing neurodegenerative diseases, comprising at least one gene selected from the group consisting of NADPH oxidase 4 (NOX4), retinol binding protein 4 (RBP4) and C-X-C motif chemokine ligand 10 (CXCL10) or proteins encoded from the genes. It has been identified that the level of the biomarkers in a neurodegenerative disease animal model is lower than that of a normal group, and an optimal biomarker combination is identified using machine learning, and thus a biomarker having higher accuracy than conventional neurodegenerative disease diagnosis methods can be provided.

IPC Classes  ?

• G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
• C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
• G06N 20/20 - Ensemble learning
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16B 25/00 - ICT specially adapted for hybridisationICT specially adapted for gene or protein expression

Abstract

The present disclosure relates to a method and apparatus for providing a medical service for diagnosing erectile dysfunction to a user terminal. The method according to an embodiment of the present disclosure may perform a first test related to cardiovascular disease risk factors by acquiring information for identifying a heart disease risk. In addition, erectile dysfunction can be diagnosed by performing a second test related to a depression scale when results of the first test are normal, performing a third test related to an erectile function index when a result of the second test is less than or equal to a second threshold value, and performing, on the basis of a result of the third test, at least one of a fourth test related to motor skills, a fifth test related to ejaculation disorder, and a sixth test related to sexual dysfunction.

IPC Classes  ?

• G16H 20/30 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16H 20/70 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
• G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
• G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
• G16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
• G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61B 5/02 - Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow

Abstract

One aspect of the present invention relates to a method for detecting target nucleic acids using plasmonic immunomagnetic nanoparticles. The method for detecting target nucleic acids using plasmonic immunomagnetic nanoparticles according to one aspect of the present invention is low-cost, allows quick and simple detection of target nucleic acids, and thus can be used in various fields such as molecular biology, medicine, and biological classification.

IPC Classes  ?

• C12Q 1/6804 - Nucleic acid analysis using immunogens
• C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
• C12Q 1/6844 - Nucleic acid amplification reactions

Abstract

An embodiment of the disclosure provides: a PCR kit for diagnosing asthma or asthma exacerbation, comprising an agent for measuring the mRNA level of a nectin-4 gene; and a method for providing information for diagnosing asthma or asthma exacerbation by using same. According to an embodiment of the disclosure, there is the effect of providing: a PCR kit for diagnosing asthma or asthma exacerbation, which enables the administration of an appropriate dose of a drug for asthma treatment by diagnosing not only asthma but also asthma exacerbation; and a method for providing information for diagnosing asthma or asthma exacerbation by using same.

IPC Classes  ?

• C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
• C12Q 1/6851 - Quantitative amplification

Abstract

One aspect relates to a method for detecting nucleic acids by using a plasmonic photothermal cross-linking colorimetric polymerase chain reaction. The method for detecting nucleic acids by using a plasmonic photothermal cross-linking colorimetric polymerase chain reaction, according to one aspect, can rapidly and simply perform multiplex detection of target nucleic acids, and thus can be used in various fields such as molecular biology, health care and biological classification.

IPC Classes  ?

• C12Q 1/6848 - Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
• C12Q 1/686 - Polymerase chain reaction [PCR]
• C12Q 1/6853 - Nucleic acid amplification reactions using modified primers or templates

Abstract

The present invention relates to a novel anti-human R-spondin-3 antibody and a use thereof. The R-spondin-3 antibody of the present invention specifically binds to human R-spondin-3 and effectively blocks WNT signaling, demonstrating excellent neutralizing capabilities. Therefore, the antibody is expected to be utilized not only as a diagnostic tool for WNT/β-catenin-related diseases, such as cancer, but also as an excellent therapeutic antibody.

IPC Classes  ?

• C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
• A61P 35/00 - Antineoplastic agents
• G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

The present invention relates to novel anti-human R-spondin 2 (RSPO2) antibodies and use thereof. The RSPO2 antibodies of the present invention specifically bind to a human RSPO2 to effectively block WNT signal transmission, thus exhibiting excellent neutralization performance, and thus are expected to be applicable as a diagnostic means for WNT//β-catenin associated diseases, for example, cancer, and as well as an excellent antibody therapeutic agent.

IPC Classes  ?

• C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
• A61P 35/00 - Antineoplastic agents
• G01N 33/574 - ImmunoassayBiospecific binding assayMaterials therefor for cancer
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

The present invention relates to an enteric formulation containing sodium bicarbonate for maintaining or improving athletic performance of high intensity or for at least a certain period of time, the enteric formulation alleviating gastrointestinal disorders. The enteric formulation, according to the present invention, in which sodium bicarbonate or a composition containing sodium bicarbonate is coated with an enteric additive, of the present invention, applies enteric properties to sodium bicarbonate so as to reduce gastrointestinal disorders that occur when sodium bicarbonate is administered while maintaining the time for which sodium bicarbonate is present at an effective blood concentration or higher even with a dose smaller than that of a conventional dose of sodium bicarbonate, and thus can be effectively used in preparations, sports supplements and the like.

IPC Classes  ?

• A61K 9/50 - Microcapsules
• A61K 33/00 - Medicinal preparations containing inorganic active ingredients
• A61P 43/00 - Drugs for specific purposes, not provided for in groups
• A61P 1/00 - Drugs for disorders of the alimentary tract or the digestive system
• A23L 33/16 - Inorganic salts, minerals or trace elements
• A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives

Abstract

The present invention relates to a bio-implantable bladder treatment device, and a method for manufacturing an electronic web and an electronic thread included therein. The bio-implantable bladder treatment device according to an embodiment of the present invention includes: an electronic web which is installable to cover the outer circumference of the bladder; and an electronic thread inserted into the electronic web to be coupled to the electronic web and configured to measure a state of the bladder.

IPC Classes  ?

• A61N 1/05 - Electrodes for implantation or insertion into the body, e.g. heart electrode
• A61N 1/36 - Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers

Abstract

Disclosed is a gait analysis method comprising the steps of: measuring plantar pressure data for each area of a foot by a plurality of sensors; preprocessing the plantar pressure data; deriving vector data of a pressure center point velocity for each area on the basis of the preprocessed data; generating a plantar pressure image in a two-dimensional matrix on the basis of the preprocessed data; estimating a stride length from the vector data of the pressure center point velocity for each area and the plantar pressure image in the two-dimensional matrix by using an artificial intelligence model; and displaying the estimated stride length and a gait analysis result.

IPC Classes  ?

• A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
• A61B 5/103 - Measuring devices for testing the shape, pattern, size or movement of the body or parts thereof, for diagnostic purposes
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Abstract

Disclosed is an apparatus for assisting an active motion of a finger including a standard stabilizer, a hyperextension-specific stabilizer having a shape being bent in a first direction, in which the finger is extended, an active motion-specific elastic part that generates an elastic force in the first direction or a second direction being an opposite direction to the first direction, and a mounting part, to which one of the standard stabilizer, the hyperextension-specific stabilizer, and the active motion-specific elastic part is selectively coupled to be separable, and on which the finger is worn.

IPC Classes  ?

• A61F 5/01 - Orthopaedic devices, e.g. long-term immobilising or pressure directing devices for treating broken or deformed bones such as splints, casts or braces

Abstract

An Ethernet harness dimension measurement method and device are disclosed. According to one embodiment of the present invention, the disclosed Ethernet harness dimension measurement method comprises the steps of: (S100) acquiring image information of an Ethernet harness; (S300) acquiring full-range vertex information about the positions of vertices in the full-range of the image information; (S400) generating head bottom reference point information on the basis of the full-range vertex information; (S500) calculating the length of a wire on the basis of the head bottom reference point information; (S600) and calculating the width of the wire on the basis of the head bottom reference point information.

IPC Classes  ?

• G01B 11/00 - Measuring arrangements characterised by the use of optical techniques
• G01B 11/03 - Measuring arrangements characterised by the use of optical techniques for measuring length, width, or thickness by measuring coordinates of points
• G06V 10/20 - Image preprocessing
• G06V 10/40 - Extraction of image or video features

Abstract

Propionibacterium acnesPropionibacterium acnes, which is the bacterium associated with acne, and thus can be advantageously used for related businesses.

IPC Classes  ?

• A61K 8/98 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution of animal origin
• A61Q 19/00 - Preparations for care of the skin
• A61K 35/60 - Fish, e.g. seahorsesFish eggs
• A61P 17/10 - Anti-acne agents
• A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
• A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives

Abstract

An inkjet head monitoring system according to an embodiment of the present disclosure may include: a head provided with a plurality of nozzles each including a piezo element and a switching element; a driver which applies a specified voltage to the plurality of nozzles; a sensing circuit which obtains a self-sensing signal from the piezo element; and at least one processor. The at least one processor may be configured to: output an injection trigger to the driver to apply a voltage to the plurality of nozzles; obtain, through the sensing circuit, the self-sensing signal from the piezo element included in the plurality of nozzles on the basis of a specified scanning frequency; extract data corresponding to at least one frequency from the obtained self-sensing signal; and monitor the status of the plurality of nozzles on the basis of the extracted data corresponding to the at least one frequency.

IPC Classes  ?

• B41J 2/14 - Structure thereof
• B41J 29/393 - Devices for controlling or analysing the entire machine

Abstract

The present disclosure relates to a sleeve gastrectomy aid device including: a guide configured to be inserted into a stomach of a patient; an expander configured to be disposed outside the guide and have a volume that changes according to an amount of air therein; a first measurer configured to measure a pressure applied to the expander and have a shape that changes in accordance with a change in the volume of the expander; and a monitor configured to be connected to the first measurer and provide resection position information through a value of the pressure measured by the first measurer.

IPC Classes  ?

• A61F 5/00 - Orthopaedic methods or devices for non-surgical treatment of bones or jointsNursing devices
• A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
• A61B 34/10 - Computer-aided planning, simulation or modelling of surgical operations
• A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
• A61B 90/92 - Identification means for patients or instruments, e.g. tags coded with colour

Abstract

The present invention relates to a fall risk assessment index extraction system and a fall risk assessment index extraction method, the system comprising: an inertial sensor mounted on a user; a signal collecting and preprocessing module for collecting a user signal from the inertial sensor, and preprocessing the user signal by removing unnecessary signals and noise from the user signal; a feature extraction module for extracting a feature vector from the user signal preprocessed in the signal collecting and preprocessing module; and a walking data location detection module for receiving an input of the feature vector to detect a walking pattern signal through a machine learning classifier, and calculating a walking index from the walking pattern signal.

IPC Classes  ?

• G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
• A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons

Abstract

The present invention relates to a fall risk prevention system and, more specifically, to a fall risk prevention system using electronic medical records, wherein electronic medical records are utilized to predict a patient's fall and calculate the risk, thereby effectively preventing the risk of fall. The fall risk prevention system using electronic medical records according to the present invention comprises: a data storage unit in which patient's medical record data is stored; a data extraction unit for extracting a necessary medical record from the data storage unit; a data preprocessing unit for performing a preprocess for analysis on the extracted data; a data classification unit for classifying the preprocessed data; a data analysis unit for analyzing the classified data and calculating a fall risk score; and a control unit for controlling the operation of the data extraction unit, the data preprocessing unit, the data classification unit, and the data analysis unit.

IPC Classes  ?

• G16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
• G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
• G06V 30/41 - Analysis of document content
• G06V 30/16 - Image preprocessing
• G06V 30/19 - Recognition using electronic means
• G06N 20/00 - Machine learning

Abstract

One aspect relates to a pharmaceutical composition for wound healing or skin tissue regeneration, the pharmaceutical composition containing an extracellular matrix and a kelp extract. According to one aspect, the extracellular matrix and the kelp extract have excellent biodegradation, swelling, protein release, cell proliferation, and biocompatibility, reduce the expression of MMP, and can convert the phenotype of macrophages from the M1 type to the M2 type, and thus can effectively reduce the time required for wound healing. Therefore, the pharmaceutical composition can be effectively used for wound healing and/or skin tissue regeneration.

IPC Classes  ?

• A61K 35/407 - LiverHepatocytes
• A61K 36/03 - Phaeophycota or phaeophyta (brown algae), e.g. Fucus
• A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
• A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
• A61P 31/04 - Antibacterial agents
• A61K 8/98 - Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof, of undetermined constitution of animal origin
• A61K 8/9711 - Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
• A61Q 19/00 - Preparations for care of the skin
• A61L 27/36 - Materials for prostheses or for coating prostheses containing ingredients of undetermined constitution or reaction products thereof

Abstract

A free motion headform (FMH) impact performance prediction device using artificial intelligence includes a data processing processor configured to generate an image by extracting a pre-processed test target image, generated by pre-processing test target design data, using a pre-trained model and generate a pre-processed test target distance value by pre-processing the test target design data. The FMH input performance prediction device also includes a machine learning processor configured to concatenate the image generated by extraction on the basis of the pre-trained model and the pre-processed test target distance value and to predict impact performance using a neural network in which parameters are updated by learning based on an image obtained by pre-processing existing design data and existing impact amount data corresponding to the existing design data. The FMH input performance prediction device further includes an output processor configured to output a value learned by the machine learning processor.

IPC Classes  ?

• G06F 30/27 - Design optimisation, verification or simulation using machine learning, e.g. artificial intelligence, neural networks, support vector machines [SVM] or training a model
• G06F 30/15 - Vehicle, aircraft or watercraft design

Abstract

A person-to-person non-face-to-face identity verification system using wireless communication is disclosed. The non-face-to-face identity verification system according to the present invention mutually exchanges a first certificate signed with a user identifier and a private key of a terminal user and a second certificate signed with a user identifier and a private key of a terminal user of a second terminal from the second terminal, verifies the received certificates with a public key of each terminal registered on on/off-chain, combines the verified certificate and a self-generated certificate to generate an integrated certificate. Accordingly, since the electronically signed confirmations are exchanged with each other and verified with public keys registered on the on/off-chain, it is possible to exchange the verified certificates non-face-to-face.

IPC Classes  ?

• H04L 9/32 - Arrangements for secret or secure communicationsNetwork security protocols including means for verifying the identity or authority of a user of the system

Abstract

A digital ID storage and federation service model is disclosed. In the digital ID storage and federation service model according to the present invention, the custodian creates a federation ID (F-ID) mapped to a digital ID received from the issuer, delivers it to the holder, and stores it in a ledger for ID sharing. When the holder submits the F-ID to a service provider while requesting the service from the service provider, the service provider requests verification from the custodian, and when all ID transaction event history is recorded in a ledger for ID transaction, the custodian delivers that verification is normally completed to the service provider, and the service provider provides the requested service to the holder.

IPC Classes  ?

• G06F 21/34 - User authentication involving the use of external additional devices, e.g. dongles or smart cards

Abstract

Disclosed are a method and apparatus for predicting brain sex and brain age from a brain image. The method for predicting brain sex and brain age according to one embodiment of the present invention may comprise the steps of: identifying a brain image from a database; preprocessing the brain image so as to be identifiable by a brain sex prediction model and a brain age prediction model; using the brain sex prediction model to predict brain sex characteristics used to determine brain sex from the preprocessed brain image; and using the brain age prediction model to predict brain age based on the brain sex characteristics from the preprocessed brain image and the predicted brain sex characteristics.

IPC Classes  ?

• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61B 5/055 - Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fieldsMeasuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• G16H 30/40 - ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G06N 3/08 - Learning methods

Abstract

The present invention relates to a composition for preventing or diagnosing glaucoma, comprising a protein as an active ingredient. The present invention put efforts into research for the development of more effective and novel diagnosis for normal-tension glaucoma that has a high incidence rate. As a result, 12 biomarkers for diagnosing normal-tension glaucoma, which are differentially expressed in the aqueous humor, have been identified. By confirming that the expression of AMBP, IGFBP2, C7, B2M, CPB2, SERPIND1, and F12 proteins is up-regulated in the aqueous humor while the expression of DCD, ENO1, DSG1, and KPRP is down-regulated, the present invention has been completed. The present invention can be very useful in early diagnosis of normal-tension glaucoma (NTG).

IPC Classes  ?

• G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
• C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
• A61P 27/02 - Ophthalmic agents

Abstract

The present invention relates to a microbiome collection device comprising: a casing having an arrangement space and an inlet hole; and an absorption member, which is arranged in the arrangement space so as to absorb a microbiome that flows in through the inlet hole. Therefore, a microbiome is directly collected from the digestive organs without collecting the microbiome from feces excreted from the body, and thus analysis efficiency of a digestive organ microbiome is enhanced.

IPC Classes  ?

• A61B 10/00 - Instruments for taking body samples for diagnostic purposesOther methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determinationThroat striking implements
• A61B 10/04 - Endoscopic instruments, e.g. catheter-type instruments
• A61B 1/04 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor combined with photographic or television appliances
• A61B 1/273 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes, gastroscopes
• A61B 1/31 - Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopesIlluminating arrangements therefor for the rectum, e.g. proctoscopes, sigmoidoscopes

Abstract

The present invention relates to a service provision system through automatic extraction and classification of medical data, comprising: a collection server that collects and stores data (hereinafter, referred to as medical data) related to treatment of a patient, obtained from a medical device; and a process management server that defines a plurality of standardized workflows for treating the patient by using the medical device, and when the treatment is performed according to a workflow selected from the plurality of workflows, automatically extracts and classifies the medical data received from a data collection module provided in the collection server, according to a pre-defined process, wherein the data collection module collects the medical data stored in the collection server and transmits same to the process management server according to a request of the process management server.

IPC Classes  ?

• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
• G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
• G06Q 10/06 - Resources, workflows, human or project managementEnterprise or organisation planningEnterprise or organisation modelling

Abstract

The present invention relates to a system and a method for actively collecting medical data on a patient, the system comprising: a collection server for collecting and storing data (hereinafter, referred to as "medical data") related to treatment of a patient, acquired from a medical device; a process management server, which defines a plurality of workflows standardized to treat the patient with the medical device and, if one of the plurality of workflows is selected by means of a medical staff terminal, provides the processes of the selected workflow to the medical staff terminal and a patient terminal; and the patient terminal, which generates a patient-active event so as to transmit the patient-active event to a process management module if patient state information according to the determination of the patient is received during treatment of the patient with the medical device according to the processes defined in the selected workflow, wherein, if the patient-active event is received, the process management server receives, through a data collection module installed in the collection server, the medical data stored in the collection server.

IPC Classes  ?

• G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
• G16H 20/40 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
• G06Q 10/06 - Resources, workflows, human or project managementEnterprise or organisation planningEnterprise or organisation modelling

Abstract

The present invention relates to a bio-implantable bladder treatment device, and a method for manufacturing an electronic web and an electronic thread included therein. The bio-implantable bladder treatment device according to an embodiment of the present invention includes: an electronic web which is installable to cover the outer circumference of the bladder; and an electronic thread inserted into the electronic web to be coupled to the electronic web and configured to measure a state of the bladder.

IPC Classes  ?

• A61N 5/06 - Radiation therapy using light
• A61N 1/36 - Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
• A61N 1/05 - Electrodes for implantation or insertion into the body, e.g. heart electrode
• A61N 1/08 - Arrangements or circuits for monitoring, protecting, controlling or indicating
• A61B 5/20 - Measuring urological functions
• A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
• A61B 5/01 - Measuring temperature of body parts
• A61B 5/391 - Electromyography [EMG] of genito-urinary organs
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons

Abstract

The present invention relates to a key isolation-based signature method. The key isolation-based signature method comprises the steps in which: each of a plurality of computing devices generates a key pair including a public key and a private key, and requests a certificate for the generated key pair from an authentication system of a certificate authority; the authentication system generates a certificate corresponding to each of the plurality of computing devices and provides the generated certificate to each of the plurality of computing devices; when the certificate is generated by the authentication system, each of the plurality of computing devices receives a key isolation value generated from a helper system which performs key isolation; each of the plurality of computing devices generates a signature key for signing by using the received key isolation value; and each of the plurality of computing devices performs a signature on data by using signature information including the public key, the certificate, and the generated signature key.

IPC Classes  ?

• H04L 9/08 - Key distribution
• H04L 9/06 - Arrangements for secret or secure communicationsNetwork security protocols the encryption apparatus using shift registers or memories for blockwise coding, e.g. D.E.S. systems
• H04L 9/32 - Arrangements for secret or secure communicationsNetwork security protocols including means for verifying the identity or authority of a user of the system

Abstract

An automatic construction device for structural construction marking is disclosed. The present invention relates to an automatic construction device for structural construction marking, the device being linked to a management platform and a site control device connected over a network so as to perform structural construction marking on a building, and comprising: a traveling unit for controlling a movement path for performing the marking; a storage unit for storing work information required for the marking; a reflection part reflecting light emitted from an external measurement unit in the site control device so that a position on the movement path can be tracked; a communication unit for transmitting/receiving the work information required for the marking to/from a main control unit in the site control device; a rebar cover thickness measurement unit for measuring the cover thickness of a rebar, provided within a work area, in order to correct a marking error of the marking; a marking unit for marking a marking line on the bottom surface of a framework in a contactless manner in order to perform the marking; and a construction control unit for controlling the traveling unit, the rebar cover thickness measurement unit, and the marking unit for the marking.

IPC Classes  ?

• E04G 21/16 - Tools or apparatus
• B25J 9/16 - Programme controls
• B25J 13/08 - Controls for manipulators by means of sensing devices, e.g. viewing or touching devices

Abstract

The present invention relates to a composition using a urine sample for diagnosis of a kidney disease and, more specifically, to a urine test composition and a kit for diagnosis of a kidney disease, each comprising an agent specifically detecting amphiregulin from a urine sample, and a method for diagnosing a kidney disease by using the composition. According to the present invention, not only is there an advantage of being able to conveniently diagnose a kidney disease in a non-invasive manner using a urine sample for a kidney disease to which early diagnosis is important, but also the application of the present invention to a patient diagnosed with chronic kidney disease can advantageously predict the plausibility of progression into end-stage renal disease in advance.

IPC Classes  ?

• G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
• G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor

Abstract

The present invention relates to a sleeve gastrectomy aid device comprising: a guide part to be inserted into a patient's stomach; an expanding part disposed outside the guide part and varying in volume in accordance with the amount of air therein; a first measurement part for measuring a pressure applied to the expanding part, and varying in shape in connection with a change in the volume of the expanding part; and a monitor part connected to the first measurement part and providing ablation location information by means of a pressure value measured by the first measurement part.

IPC Classes  ?

• A61B 17/34 - TrocarsPuncturing needles
• A61B 17/3205 - Excision instruments
• A61F 5/00 - Orthopaedic methods or devices for non-surgical treatment of bones or jointsNursing devices
• A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
• A61B 17/32 - Surgical cutting instruments
• A61B 17/00 - Surgical instruments, devices or methods

Abstract

The present invention relates to a use of a pharmaceutical composition for treating stroke or sequelae following stroke, the composition comprising a phosphodiesterase type 5 activity inhibitor and a Rho-associated kinase (ROCK) inhibitor. The present invention relates to a use of a pharmaceutical composition for treating stroke or sequelae following stroke, the composition comprising a phosphodiesterase type 5 activity inhibitor and a Rho-associated kinase (ROCK) inhibitor. The present inventors have performed research, based on clinical knowledge related to stroke treatment, in order to use sildenafil and a ROCK inhibitor in combination to treat stroke or sequelae caused by stroke, and as a result, confirmed for the first time that stroke or sequelae caused by stroke were significantly improved when sildenafil and a ROCK inhibitor were co-administered compared to when sildenafil or the ROCK inhibitor was administered by itself. Therefore, it is expected that a pharmaceutical composition according to the present invention will be able to be effectively used for treating or studying stroke or stroke-related sequelae.

IPC Classes  ?

• A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
• A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
• A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

The present invention pertains to a method for producing a long-fiber composite in which a fiber bundle is impregnated with a non-Newtonian resin. More specifically, the present invention pertains to a method for producing a thermoplastic long-fiber composite, wherein the efficiency of a non-Newtonian resin impregnation process is improved using Equation 1 representing the correlation between the penetration pressure, effective viscosity, transverse permeability, and average penetration velocity of the non-Newtonian resin, and the thickness of the fiber bundle.

IPC Classes  ?

• B29C 70/00 - Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
• B29B 15/00 - Pretreatment of the material to be shaped, not covered by groups
• B29C 70/28 - Shaping operations therefor
• B29C 70/50 - Shaping or impregnating by compression for producing articles of indefinite length, e.g. prepregs, sheet moulding compounds [SMC] or cross moulding compounds [XMC]
• B29C 70/52 - Pultrusion, i.e. forming and compressing by continuously pulling through a die
• B29C 70/54 - Component parts, details or accessoriesAuxiliary operations
• B29C 70/68 - Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers
• B29C 70/78 - Moulding material on one side only of the preformed part
• C08J 5/00 - Manufacture of articles or shaped materials containing macromolecular substances
• C08J 5/10 - Reinforcing macromolecular compounds with loose or coherent fibrous material characterised by the additives used in the polymer mixture
• B29K 105/04 - Condition, form or state of moulded material cellular or porous
• B29K 105/10 - Condition, form or state of moulded material containing reinforcements, fillers or inserts of continuous length, e.g. cords, rovings, mats, fabrics, strands or yarns oriented

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating muscular atrophy or cachexia, comprising an extract containing ginseng-derived gintonin, a fraction thereof, or gintonin, as an active ingredient.

IPC Classes  ?

• A61K 36/258 - Panax (ginseng)
• A61K 38/14 - Peptides containing saccharide radicalsDerivatives thereof
• A61K 38/16 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
• A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
• A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives

Abstract

The present invention relates to a nucleic acid isolation buffer composition, a nucleic acid isolation kit in which a membrane filter comprising same is provided, and a nucleic acid isolation method, wherein the nucleic acid isolation buffer composition has excellent compatibility with membrane filters of various materials, and enables the excellent isolation of nucleic acids from various samples, and, particularly, a nucleic acid isolation kit comprising same enables column-based one-tube PCR, and a nucleic acid isolation method using same enables the direct application of the membrane filter, on which nucleic acids are immobilized, to PCR without a separate elution process. Therefore, the nucleic acid isolation composition, the kit and the isolation method according to the present invention can be effectively used in rapid diagnosis onsite.

IPC Classes  ?

• C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
• C12Q 1/6806 - Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
• C12Q 1/686 - Polymerase chain reaction [PCR]

Abstract

A device for producing nanoparticles includes: a first connector comprising a first supply tube fitting member, a second supply tube fitting member, and a first discharge tube fitting member; a first tube having one side connected to the first supply tube fitting member; a second tube having one side connected to the second supply tube fitting member; a first conduit having one side connected to the first discharge tube fitting member; a first supply connected to another side of the first tube to supply a first material to the first conduit; and a second supply connected to another side of the second tube to supply a second material to the first conduit.

IPC Classes  ?

• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 9/51 - Nanocapsules
• B01F 23/40 - Mixing liquids with liquidsEmulsifying
• B01F 23/451 - Mixing liquids with liquidsEmulsifying using flow mixing by injecting one liquid into another
• B01F 25/31 - Injector mixers in conduits or tubes through which the main component flows
• B01F 35/71 - Feed mechanisms
• C07F 15/02 - Iron compounds
• F16L 41/02 - Branch units, e.g. made in one piece, welded, riveted
• F16L 41/03 - Branch units, e.g. made in one piece, welded, riveted comprising junction pieces for four or more pipe members
• B01F 25/00 - Flow mixersMixers for falling materials, e.g. solid particles
• B01F 101/00 - Mixing characterised by the nature of the mixed materials or by the application field

Abstract

The present invention relates to a sleeve gastrectomy aid device, characterized by comprising: a guide unit inserted into the stomach of a patient; a plurality of expandable units, arranged along a length direction of the guide unit, and each having a volume variable according to an air amount therein; a sealing unit installed at the guide unit and sealing the plurality of expandable units; an injection unit connected to the sealing unit and injecting air into the expandable units; and a measurement unit positioned inside the expandable units and measuring a pressure value of the expandable units.

IPC Classes  ?

• A61B 17/3205 - Excision instruments
• A61B 17/32 - Surgical cutting instruments
• A61F 5/00 - Orthopaedic methods or devices for non-surgical treatment of bones or jointsNursing devices
• A61B 17/072 - Surgical staplers for applying a row of staples in a single action, e.g. the staples being applied simultaneously
• A61B 17/11 - Surgical instruments, devices or methods for closing wounds or holding wounds closedAccessories for use therewith for performing anastomosisButtons for anastomosis
• A61B 17/34 - TrocarsPuncturing needles

Abstract

The present invention relates to a portable real-time PCR device and a PCR measurement method using same. A portable real-time PCR device according to an embodiment of the present invention comprises: a base part having an installation space; a plurality of lower heating units installed in the installation space of the base part; a lower optical measurement unit, which is installed in the base part, is arranged at a position different from that of the lower heating units, and provides measurement light or receives the measurement light; and a chamber assembly comprising a plurality of chamber parts loaded on each of the lower heating units and the lower optical measurement unit, the chamber parts being provided to be movable from any one of the lower heating units to another one of the lower heating units or the lower optical measurement unit, wherein each chamber part comprises a chamber part body for accommodating a chamber unit having a specimen unit accommodation space in which a specimen unit is accommodated, the chamber unit comprises a chamber unit body in which the specimen unit accommodation space is formed and a cap unit shielding the accommodation space of the chamber unit body at the top, and the specimen unit is formed such that the aspect ratio, which is the ratio of height to width, is greater than 0 and less than 1.

IPC Classes  ?

• B01L 7/00 - Heating or cooling apparatusHeat insulating devices
• C12Q 1/686 - Polymerase chain reaction [PCR]

Abstract

An embodiment of the present invention provides: a PCR kit for diagnosing asthma or asthma exacerbation, comprising an agent for measuring the mRNA level of a nectin-4 gene; and a method for providing information for diagnosing asthma or asthma exacerbation by using same. According to an embodiment of the present invention, there is the effect of providing: a PCR kit for diagnosing asthma or asthma exacerbation, which enables the administration of an appropriate dose of a drug for asthma treatment by diagnosing not only asthma but also asthma exacerbation; and a method for providing information for diagnosing asthma or asthma exacerbation by using same.

IPC Classes  ?

• C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Abstract

A digital ID storage and linkage service model is disclosed. The digital ID storage and linkage service model according to the present invention is configured such that a custodian generates a federation ID (F-ID) mapped to a digital ID received from an issuer, delivers the F-ID to a holder and, simultaneously, stores the F-ID in a ledger for ID sharing, the service provider makes a request for verification to the custodian if the holder submits the F-ID to a service provider while requesting a service, the custodian informs the service provider that the verification has been properly completed if all ID transaction event details are recorded in a ledger for ID transaction, and the service provider provides the requested service to the holder.

IPC Classes  ?

• H04L 9/40 - Network security protocols
• G06Q 20/40 - Authorisation, e.g. identification of payer or payee, verification of customer or shop credentialsReview and approval of payers, e.g. check of credit lines or negative lists
• H04L 65/40 - Support for services or applications

Abstract

The present invention relates to a sleeve gastrectomy assisting device, comprising: a resection guide unit which is inserted into the stomach of a patient and has a variable shape; a measurement unit which is installed in the resection guide unit and measures pressure applied to the resection guide unit; and a monitor unit which is connected to the measurement unit and provides at least one of resection length information and resection position information by means of a pressure value measured by the measurement unit.

IPC Classes  ?

• A61B 17/32 - Surgical cutting instruments
• A61B 17/11 - Surgical instruments, devices or methods for closing wounds or holding wounds closedAccessories for use therewith for performing anastomosisButtons for anastomosis
• A61F 5/00 - Orthopaedic methods or devices for non-surgical treatment of bones or jointsNursing devices
• A61B 5/07 - Endoradiosondes
• A61B 34/20 - Surgical navigation systemsDevices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
• A61B 34/00 - Computer-aided surgeryManipulators or robots specially adapted for use in surgery
• A61B 17/34 - TrocarsPuncturing needles

Abstract

The present invention relates to a cell penetrating peptide-linker-anticancer drug conjugate for treating colorectal cancer, and a pharmaceutical composition, for preventing or treating colorectal cancer, comprising same. Particularly, the conjugate, in which octaarginine (R8) CPP is bound with oxaliplatin by means of a heterogeneous linker, exhibits effective cellular uptake and strong cytotoxicity effect against colorectal cancer cells, and thus is effective in treating colorectal cancer.

IPC Classes  ?

• A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
• A61K 31/555 - Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
• A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
• A61P 35/00 - Antineoplastic agents

Abstract

Disclosed are a deep-learning-based fundus image classification device and method for diagnosing ophthalmological diseases. The deep-learning-based fundus image classification device for diagnosing ophthalmological diseases, according to one aspect of the present invention, comprises: a data preprocessing unit, which preprocesses retinal fundus image data to normalize image data before model training; and a retinal image classification unit, which trains and tests the preprocessed retinal fundus image data to classify retinal images, and uses stratified 10-fold cross validation to classify retinal images.

IPC Classes  ?

• A61B 3/12 - Objective types, i.e. instruments for examining the eyes independent of the patients perceptions or reactions for looking at the eye fundus, e.g. ophthalmoscopes
• A61B 3/00 - Apparatus for testing the eyesInstruments for examining the eyes
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
• G16H 30/40 - ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
• G06N 3/08 - Learning methods
• G06T 7/00 - Image analysis

Abstract

The present disclosure relates to a marker for diagnosing neurodegenerative diseases, and a use thereof, and, more particularly, to: a marker composition for diagnosing neurodegenerative diseases; a composition for diagnosing neurodegenerative diseases, containing a preparation for measuring the glutathionylation level of a FUS protein; a kit for diagnosing neurodegenerative diseases, containing the composition; and an information providing method for diagnosing neurodegenerative diseases by using same. The inventors have discovered that a glutathionylated FUS protein functions as a marker for diagnosing neurodegenerative diseases, and thus a composition for diagnosing neurodegenerative diseases, according to the present disclosure, is expected to contribute to early diagnosis of patients with neurodegenerative diseases. The present disclosure relates to a marker for diagnosing neurodegenerative diseases, and a use thereof, and, more particularly, to: a marker composition for diagnosing neurodegenerative diseases; a composition for diagnosing neurodegenerative diseases, containing a preparation for measuring the glutathionylation level of a FUS protein; a kit for diagnosing neurodegenerative diseases, containing the composition; and an information providing method for diagnosing neurodegenerative diseases by using same. The inventors have discovered that a glutathionylated FUS protein functions as a marker for diagnosing neurodegenerative diseases, and thus a composition for diagnosing neurodegenerative diseases, according to the present disclosure, is expected to contribute to early diagnosis of patients with neurodegenerative diseases. In addition, the present disclosure identifies GSTO1 or GstO2, which is a factor inducing the deglutathionylation of a FUS protein, so as to ascertain effects of inhibiting brain cytoplasmic aggregation and neurocytotoxicity by using same, and thus is expected to be effectively used for preventing, treating or alleviating neurodegenerative diseases.

IPC Classes  ?

• G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
• A61K 38/44 - Oxidoreductases (1)

Abstract

A peptide and a peptide multimer according to the present invention serve to control tight bonding between cells, and thereby facilitate the absorption, through a mucous membrane, of an active ingredient of co-administered drugs and the like. Thus, the bioavailability of the active ingredient can be significantly improved, and as a result, the therapeutic effect of the active ingredient can be significantly improved.

IPC Classes  ?

• A61K 8/64 - ProteinsPeptidesDerivatives or degradation products thereof

Abstract

The present invention relates to a composition using a urine sample for diagnosis of a kidney disease and, more specifically, to a urine test composition and a kit for diagnosis of a kidney disease, each comprising an agent specifically detecting amphiregulin from a urine sample, and a method for diagnosing a kidney disease by using the composition. According to the present invention, not only is there an advantage of being able to conveniently diagnose a kidney disease in a non-invasive manner using a urine sample for a kidney disease to which early diagnosis is important, but also the application of the present invention to a patient diagnosed with chronic renal failure can advantageously predict the plausibility of progression into end-stage renal failure in advance.

IPC Classes  ?

• G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
• G01N 33/53 - ImmunoassayBiospecific binding assayMaterials therefor

Abstract

A method for verifying a drone included in an industrial Internet of Things (IIoT) system, using a petri-net modeling is disclosed. In an embodiment, the method includes a step of modeling the IIoT system as a hierarchical petri-net (modeling step); and a step of verifying whether the drone has security vulnerability on the basis of the hierarchical petri-net model (verification step), wherein the verification step can determine that a drone has security vulnerability when at least one of a plurality of determination factors provided as places to the hierarchical petri-net model determines that the drone is operating abnormally.

IPC Classes  ?

• G06F 21/57 - Certifying or maintaining trusted computer platforms, e.g. secure boots or power-downs, version controls, system software checks, secure updates or assessing vulnerabilities
• G06N 7/00 - Computing arrangements based on specific mathematical models
• H04L 9/40 - Network security protocols
• H04L 67/12 - Protocols specially adapted for proprietary or special-purpose networking environments, e.g. medical networks, sensor networks, networks in vehicles or remote metering networks

Abstract

The present invention relates to a use of a pharmaceutical composition for treating stroke or sequelae following stroke, the composition comprising a phosphodiesterase type 5 activity inhibitor and a Rho-associasted kinase (ROCK) inhibitor. The present inventors have performed research, based on clinical knowledge related to stroke treatment, in order to use sildenafil and a ROCK inhibitor in combination to treat stroke or sequelae caused by stroke, and as a result, confirmed for the first time that stroke or sequelae caused by stroke were significantly improved when sildenafil and a ROCK inhibitor were administered in combination compared to when sildenafil or the ROCK inhibitor was administered by itself. Therefore, it is expected that a pharmaceutical composition according to the present invention will be able to be effectively used for treating or studying stroke or stroke-related sequelae.

IPC Classes  ?

• A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
• A61K 31/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
• A61K 31/551 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
• A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
• A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
• A61P 25/22 - Anxiolytics
• A61P 7/02 - Antithrombotic agentsAnticoagulantsPlatelet aggregation inhibitors
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

Disclosed is an ICT-based rehabilitation therapy and assessment method/system using dual-task stacking cones. The ICT-based rehabilitation therapy and assessment method, according to the present invention, is a rehabilitation therapy and assessment method carried out by an assessment terminal of the ICT-based rehabilitation therapy and assessment system using dual-task stacking cones, the method comprising the steps of: receiving measurement values of the tilt and degree of tremor of wrist movement, from a wrist band worn on the wrist of a patient; receiving cone detection values from a stacking board; and assessing the motor function of the patient on the basis of the measurement values received from the wrist band, and the detection values received from the stacking board.

IPC Classes  ?

• A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• G16H 20/30 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
• G16H 20/70 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
• A63B 23/16 - Exercising apparatus specially adapted for particular parts of the body for limbs, i.e. upper or lower limbs, e.g. simultaneously for upper limbs for hands or fingers
• A63B 24/00 - Electric or electronic controls for exercising apparatus of groups

Abstract

Bifidobacterium longumBifidobacterium bifidumBifidobacterium bifidum HN002 strain. According to the anti-obesity effect that the strains or cultures thereof effectuate, the present invention provides a use of the strains or cultures thereof in preventing, treating, or alleviating obesity.

IPC Classes  ?

• C12N 1/20 - BacteriaCulture media therefor
• A61K 35/745 - Bifidobacteria
• A61P 3/04 - AnorexiantsAntiobesity agents
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23K 10/18 - Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
• C12R 1/01 - Bacteria or actinomycetales

Abstract

Provided is a method of evaluating a project, which is performed by a server. The method may include determining team members who are to perform a project, receiving project activity contents generated by at least one of the team members and transmitting the project activity contents to a node on a blockchain. The project activity contents may include an execution completion report on at least one of tasks configuring the project, execution results of the project, evaluation of the results by the team members, and feedback for the evaluation.

IPC Classes  ?

• G06Q 10/00 - AdministrationManagement
• G06Q 10/0631 - Resource planning, allocation, distributing or scheduling for enterprises or organisations
• G06Q 10/0639 - Performance analysis of employeesPerformance analysis of enterprise or organisation operations
• G06F 16/27 - Replication, distribution or synchronisation of data between databases or within a distributed database systemDistributed database system architectures therefor

Abstract

The present disclosure relates to a fiber for manufacturing a stretchable hydrophobic fiber article, the fiber including silica nanoparticles which are surface-modified such that the silica nanoparticles include a hydrocarbon chain, and a styrene-based thermoplastic elastomer, a stretchable hydrophobic fiber article manufactured therefrom, and a manufacturing method thereof. A fiber and a fiber article according to the present disclosure may have high hydrophobicity, preferably both superhydrophobicity and elasticity. Further, as the fiber and fiber article have excellent mechanical stability and chemical durability, the fiber and fiber article may stably exhibit the aforementioned high hydrophobicity and elasticity even under the harsh conditions.

IPC Classes  ?

• D06M 11/79 - Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereofSuch treatment combined with mechanical treatment, e.g. mercerising with silicon or compounds thereof with silicon dioxide, silicic acids or their salts
• C08L 25/06 - Polystyrene
• C08K 3/36 - Silica
• C08K 5/02 - Halogenated hydrocarbons
• D01D 5/00 - Formation of filaments, threads, or the like
• D01D 5/38 - Formation of filaments, threads, or the like during polymerisation
• B82Y 30/00 - Nanotechnology for materials or surface science, e.g. nanocomposites
• B82Y 40/00 - Manufacture or treatment of nanostructures
• D06M 101/18 - Synthetic fibres consisting of macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Abstract

An apparatus for crash performance prediction of a vehicle includes: a data processor configured to generate a test target overlap image by pre-processing test target design data; and an output device configured to output at least one of a predicted impact value and a predicted impact rating value for an input of the test target overlap image based on a crash performance prediction model by machine learning the existing overlap image of pre-processed existing design data and the existing impulse data corresponding to the existing design data.

IPC Classes  ?

• G06T 7/00 - Image analysis
• G06N 3/08 - Learning methods
• G06V 10/20 - Image preprocessing
• G06F 18/214 - Generating training patternsBootstrap methods, e.g. bagging or boosting
• G06V 10/764 - Arrangements for image or video recognition or understanding using pattern recognition or machine learning using classification, e.g. of video objects
• G06V 10/774 - Generating sets of training patternsBootstrap methods, e.g. bagging or boosting
• G06V 10/82 - Arrangements for image or video recognition or understanding using pattern recognition or machine learning using neural networks

Abstract

The present invention pertains to a method for producing a long-fiber composite in which a fiber bundle is impregnated with a non-Newtonian resin. More specifically, the present invention pertains to a method for producing a thermoplastic long-fiber composite, wherein the efficiency of a non-Newtonian resin impregnation process is improved using Equation 1 representing the correlation between the penetration pressure, effective viscosity, vertical penetration, and average penetration rate of the non-Newtonian resin, and the thickness of the fiber bundle.

IPC Classes  ?

• B29C 70/28 - Shaping operations therefor
• B29C 70/06 - Fibrous reinforcements only
• B29C 70/54 - Component parts, details or accessoriesAuxiliary operations
• B29C 70/68 - Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers
• C08J 5/10 - Reinforcing macromolecular compounds with loose or coherent fibrous material characterised by the additives used in the polymer mixture
• C08J 5/00 - Manufacture of articles or shaped materials containing macromolecular substances
• B29K 105/08 - Condition, form or state of moulded material containing reinforcements, fillers or inserts of continuous length, e.g. cords, rovings, mats, fabrics, strands or yarns

Abstract

The present invention relates to a composition for the diagnosis, prevention, or treatment of neutrophilic pulmonary inflammatory diseases by using granulocyte-colony stimulating factor (G-CSF) and interleukin-1β (IL-1β). According to the present invention, G-CSF can be used as a biomarker for the diagnosis of neutrophilic pulmonary inflammatory diseases, and IL-1β is expected to be usefully applicable as a therapeutic target for neutrophilic pulmonary inflammatory diseases in related fields.

IPC Classes  ?

• G01N 33/68 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving proteins, peptides or amino acids
• C12Q 1/6883 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
• C07K 16/24 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
• A61P 11/00 - Drugs for disorders of the respiratory system
• A61K 39/00 - Medicinal preparations containing antigens or antibodies

Abstract

An apparatus for predicting an injury level of a user of a vehicle may include: a communication circuit configured to communicate with an external device; a memory configured to store a genetic algorithm and a machine learning model; and a processor electrically connected with the communication circuit and the memory. The processor may be configured to: obtain, via the communication circuit, traffic accident data associated with a traffic accident; select input data, which includes at least a part of the traffic accident data, for training of the machine learning model, the input data selected using the genetic algorithm; train the machine learning model using the input data; and predict an injury level of the user of the vehicle using the trained machine learning model when the training of the machine learning model is completed.

IPC Classes  ?

• G07C 5/08 - Registering or indicating performance data other than driving, working, idle, or waiting time, with or without registering driving, working, idle, or waiting time
• B60W 40/08 - Estimation or calculation of driving parameters for road vehicle drive control systems not related to the control of a particular sub-unit related to drivers or passengers
• G06N 5/04 - Inference or reasoning models
• G06N 20/10 - Machine learning using kernel methods, e.g. support vector machines [SVM]
• G07C 5/00 - Registering or indicating the working of vehicles
• G06N 3/08 - Learning methods
• G06N 3/12 - Computing arrangements based on biological models using genetic models
• G06N 20/00 - Machine learning
• G06N 7/00 - Computing arrangements based on specific mathematical models

Abstract

The present invention relates to a secondary battery. A secondary battery according to an embodiment of the present invention comprises: a cathode including a cathode active material part that is reduced by receiving electrons and a current collector supporting the cathode active material part; an anode including an anode active material part that emits electrons while being oxidized; and an electrolyte part that is a transfer passage through which ions are transferred between the cathode and the anode; and a separator in which at least a portion is hexagonal boron nitride nanosheets (BNNSs).

IPC Classes  ?

• H01M 2/16 - Separators; Membranes; Diaphragms; Spacing elements characterised by the material
• H01M 2/14 - Separators; Membranes; Diaphragms; Spacing elements
• H01M 10/052 - Li-accumulators
• H01M 8/1016 - Fuel cells with solid electrolytes characterised by the electrolyte material
• H01M 8/1041 - Polymer electrolyte composites, mixtures or blends
• C01B 21/064 - Binary compounds of nitrogen with metals, with silicon, or with boron with boron
• H01M 8/1004 - Fuel cells with solid electrolytes characterised by membrane-electrode assemblies [MEA]

Abstract

The present invention discloses a privacy masking method using format-preserving encryption in an image security system, and a recording medium for performing the method. In a privacy masking method using format-preserving encryption in an image security system according to an aspect of the present invention, an image corresponding to a privacy region is encrypted using format-preserving encryption, so that it is possible to prevent waste of additional storage space required for encryption and to solve a problem of exposure of personal information.

IPC Classes  ?

• G06F 21/00 - Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
• G06F 21/62 - Protecting access to data via a platform, e.g. using keys or access control rules
• G06F 21/60 - Protecting data
• H04L 9/40 - Network security protocols
• G06V 40/16 - Human faces, e.g. facial parts, sketches or expressions

Abstract

The present invention relates to a Doherty combiner used in a Doherty power amplifier, the Doherty combiner comprising: a phase shift section connected to one end of a carrier amplifier so as to change a phase of an RF signal output from the carrier amplifier; a matching section connected to an output terminal of the Doherty power amplifier so as to impedance-match an output of the Doherty power amplifier; and a bandwidth improvement section connected to one end of a peaking amplifier so as to change at least one of a phase bandwidth and an amplitude bandwidth of the Doherty power amplifier.

IPC Classes  ?

• H03F 1/02 - Modifications of amplifiers to raise the efficiency, e.g. gliding Class A stages, use of an auxiliary oscillation
• H03F 1/32 - Modifications of amplifiers to reduce non-linear distortion
• H03F 1/56 - Modifications of input or output impedances, not otherwise provided for
• H03F 3/195 - High-frequency amplifiers, e.g. radio frequency amplifiers with semiconductor devices only in integrated circuits
• H03F 3/24 - Power amplifiers, e.g. Class B amplifiers, Class C amplifiers of transmitter output stages
• H03F 3/60 - Amplifiers in which coupling networks have distributed constants, e.g. with waveguide resonators

Abstract

Disclosed is a security USB dongle for a USB memory without a security function. A security USB dongle connected between a host and a USB memory to mediate transmission and reception of data, according to one aspect of the present invention, comprises: a USB connector physically connected to the host and the USB memory so as to transmit and receive data; and a security setting unit which encrypts or decrypts the data transmitted and received to maintain the confidentiality of the data, or intermittently controls access from the host to the USB memory so as to manipulate/reverse-manipulate a file system such that only an authorized user or owner can access the memory.

IPC Classes  ?

• G06F 21/85 - Protecting input, output or interconnection devices interconnection devices, e.g. bus-connected or in-line devices
• G06F 21/71 - Protecting specific internal or peripheral components, in which the protection of a component leads to protection of the entire computer to assure secure computing or processing of information
• G06F 21/60 - Protecting data

Abstract

A method and a system for managing data on the basis of proxy re-encryption in an IoT lightweight terminal environment are disclosed. The method for managing data on the basis of proxy re-encryption in an IoT lightweight terminal environment, according to one aspect of the present invention, can provide a terminal management method on the basis of a proxy re-encryption method, thereby decrypting received data by using a private key provided only to a trusted user in a step of managing a re-encryption key. In addition, compared to a conventional inter-terminal encryption communication method, the present invention can reduce the increasing number of communications in a data encryption transmission step by using re-encryption.

IPC Classes  ?

• G08B 21/02 - Alarms for ensuring the safety of persons
• G08B 21/04 - Alarms for ensuring the safety of persons responsive to non-activity, e.g. of elderly persons
• A45F 3/12 - Shoulder-pads
• A45C 15/00 - Purses, bags, luggage or other receptacles covered by groups , combined with other articles
• A45F 3/00 - Travelling or camp articlesSacks or packs carried on the body

Abstract

Disclosed is a programming practice system and method. A programming practice system according to one aspect of the present invention comprises: a client device including one or more computing devices and transmitting a program source file or a compile request signal input from a learner or teacher; a web server connected to the client device through a network; and a docker server connected to the web server through the network, generating a development environment in advance as an image, and generating a container on the basis of the image.

IPC Classes  ?

• G09B 19/00 - Teaching not covered by other main groups of this subclass
• G06Q 50/10 - Services

Abstract

The present invention relates to a CPT-bound compound or a pharmaceutically acceptable salt thereof, the CPT-bound compound being obtained by binding CPT (or a CPT derivative) and guanidine to a reduced monosaccharide. The CPT-bound compound enhances solubility and cell permeability of the CPT drug, which makes it possible to effectively deliver CPT to target cells. Therefore, a pharmaceutical composition comprising, as an active ingredient, the CPT-bound compound or a pharmaceutically acceptable salt thereof is expected to be able to effectively treat cancer, in particular, colorectal cancer, even with a low dose of CPT.

IPC Classes  ?

• A61P 35/00 - Antineoplastic agents
• A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
• A61K 31/4745 - QuinolinesIsoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines

Abstract

The present invention relates to a marker for diagnosing neurodegenerative diseases, and a use thereof, and, more particularly, to: a marker composition for diagnosing neurodegenerative diseases; a composition for diagnosing neurodegenerative diseases, containing a preparation for measuring the glutathionylation level of a FUS protein; a kit for diagnosing neurodegenerative diseases, containing the composition; and an information providing method for diagnosing neurodegenerative diseases by using same. The inventors have discovered that a glutathionylated FUS protein functions as a marker for diagnosing neurodegenerative diseases, and thus a composition for diagnosing neurodegenerative diseases, according to the present invention, is expected to contribute to early diagnosis of patients with neurodegenerative diseases. In addition, the present invention identifies GSTO1 or GstO2, which is a factor inducing the deglutathionylation of a FUS protein, so as to ascertain effects of inhibiting brain cytoplasmic aggregation and neurocytotoxicity by using same, and thus is expected to be effectively used for preventing, treating or alleviating neurodegenerative diseases.

IPC Classes  ?

• A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
• A61K 38/45 - Transferases (2)
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

The present invention relates to a secondary battery using Prussian blue powder as a cathode active material . A secondary battery using Prussian blue powder as a cathode active material according to an embodiment of the present invention comprises: a cathode including a cathode active material part that receives electrons and is reduced and a current collector for supporting the cathode active material part; an anode including an anode active material part that emits electrons while being oxidized; and an electrolyte part which is a passage through which ions move between the anode and the cathode, wherein the cathode active material part comprises a Prussian blue powder, a conductive material, and a binder, and with respect to the total weight of the cathode active material part, the content of the Prussian blue powder is 78 wt% to 83 wt%, the content of the conductive material is 5 wt% to 12 wt%, and the content of the binder is 5 wt% to 13 wt%.

IPC Classes  ?

• H01M 4/58 - Selection of substances as active materials, active masses, active liquids of inorganic compounds other than oxides or hydroxides, e.g. sulfides, selenides, tellurides, halogenides or LiCoFySelection of substances as active materials, active masses, active liquids of polyanionic structures, e.g. phosphates, silicates or borates
• H01M 4/62 - Selection of inactive substances as ingredients for active masses, e.g. binders, fillers
• H01M 10/36 - Accumulators not provided for in groups

Abstract

A peptide and a peptide multimer according to the present invention serve to control tight bonding between cells, and thereby facilitate the absorption, through a mucous membrane, of active ingredients of co-administered drugs and the like. Thus, the bioavailability of the active ingredients can be significantly improved, and as a result, the therapeutic effect of the active ingredients can be significantly improved.

IPC Classes  ?

• A61K 38/08 - Peptides having 5 to 11 amino acids
• A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein
• A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

66]3-complex ions are bonded to Ni2+66]3-complex ions are bonded to Ni2+66]3-complex ions and S2- ions.

IPC Classes  ?

• B01J 31/16 - Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
• B01J 35/10 - Solids characterised by their surface properties or porosity
• B01J 37/03 - PrecipitationCo-precipitation
• B01J 37/30 - Ion-exchange
• B01J 37/08 - Heat treatment
• H01M 4/90 - Selection of catalytic material
• H01M 4/88 - Processes of manufacture

Abstract

The present invention relates to a pressure feedback device for manual therapy, the device comprising: thimble-type tubes having insertion holes into which fingers can be inserted; sensor parts attached to the thimble-type tubes and measuring pressure input when pressure is applied to the body of a subject to be treated; a display part for displaying pressure measurement information measured by the sensor parts; and a wristband part formed in a band shape coupled to the display part and wearable on the wrist of a clinician. According to the present invention, when a clinician performs manual therapy on a patient while wearing the thimble-type tubes, having the attached pressure sensors, on the clinician's fingers, real-time feedback is provided by measuring finger pressure, thus enabling safe therapy to be performed with uniform pressure. Drawing_references_to_be_translated

IPC Classes  ?

• A61H 37/00 - Accessories for massage
• A61H 23/06 - Hand percussion

Abstract

Disclosed is a system for monitoring information about muscle tension relief and muscle activation. The system for monitoring information about muscle tension relief and muscle activation according to an aspect of the present invention may be used as sportswear or daywear interchangeably, since the clothing (a wearable device) is transformed to fit the body curvature of a user as current flows, due to the specificity of material (shape memory alloy wires and/or mesh bands).

IPC Classes  ?

• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61B 5/0488 - Electromyography
• A61N 1/36 - Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers

Abstract

An airway apparatus is disclosed. The airway apparatus according to an embodiment of the present invention comprises: a main body having one end inserted into the oral cavity to block movement of the tongue and the other end exposed outside the oral cavity, the main body including an air flow path passing through the one end and the other end; a first balloon which is provided at the one end of the main body and is expanded by air supplied through a first air supply hole formed in communication with the air flow path at the one end of the main body; and an opening/closing unit for opening/closing the first air supply hole by using a sliding member which includes a first through-hole in communication with the first air supply hole and slides along the air flow path in close contact with the inner wall of the main body to make the air flow path and the first air supply hole be in communication with each other when the first through hole is located at the first air supply hole.

IPC Classes  ?

• A61M 16/04 - Tracheal tubes
• A61M 39/24 - Check- or non-return valves

Abstract

In one embodiment of the present invention, a method for verifying a drone included in an industrial Internet of Things (IIoT) system, by using petri-net modeling, according to one embodiment, comprises: a modeling step of modeling the IIoT system as a hierarchical petri-net; and a verification step of verifying whether the drone has security vulnerability on the basis of the hierarchical petri-net model, wherein the verification step can determine that the drone has security vulnerability when at least one of a plurality of determination factors provided as places to the hierarchical petri-net model determines that the drone is operating abnormally.

IPC Classes  ?

• B64F 5/60 - Testing or inspecting aircraft components or systems
• H04L 29/06 - Communication control; Communication processing characterised by a protocol
• H04L 29/08 - Transmission control procedure, e.g. data link level control procedure

Abstract

Disclosed are a traffic management method in a mobile edge cloud for improving the quality of mobile video and a device therefor. A traffic management apparatus in a mobile edge cloud for improving the quality of mobile video, according to an aspect of the present invention, has the effect of improving the quality of experience (QoE) of a mobile video user by effectively managing the traffic of a mobile terminal by a network through the mobile edge cloud.

IPC Classes  ?

• H04N 21/24 - Monitoring of processes or resources, e.g. monitoring of server load, available bandwidth or upstream requests
• H04N 21/414 - Specialised client platforms, e.g. receiver in car or embedded in a mobile appliance
• H04N 21/647 - Control signaling between network components and server or clientsNetwork processes for video distribution between server and clients, e.g. controlling the quality of the video stream, by dropping packets, protecting content from unauthorised alteration within the network, monitoring of network load or bridging between two different networks, e.g. between IP and wireless
• G06N 99/00 - Subject matter not provided for in other groups of this subclass
• H04W 36/02 - Buffering or recovering information during reselection
• H04W 36/00 - Handoff or reselecting arrangements

Abstract

The present invention relates to an LC balun having excellent phase and amplitude balance characteristics in a wide band, the LC balun comprising: a first LC circuit unit which includes: a first LC lumped element configured on the basis of a π-type CLC lumped element equivalent to a first transmission line having a first electrical length; and a first LC resonant circuit added to the first LC lumped element; and a second LC circuit unit which includes: a second LC lumped element configured on the basis of a π-type LCL lumped element equivalent to a second transmission line having a second electrical length; and a second LC resonant circuit added to the second LC lumped element.

IPC Classes  ?

• H03H 7/42 - Networks for transforming balanced signals into unbalanced signals and vice versa, e.g. baluns
• H03H 7/01 - Frequency selective two-port networks

Abstract

Bifidobacterium longumLactobacillus rhamnosusLactobacillus rhamnosus, of the present invention, causes browning of white adipocytes and, particularly, it has been confirmed that beige adipocyte- and brown adipocyte-specific gene expression significantly increases over that of an untreated control group. In addition, as a result of experimentation on high fat diet-induced obese mice is carried out, each strain exhibits a weight gain inhibitory effect more significant than that of a negative control group, and an effect of increased expression of a thermogenesis-specific gene, in the white adipocytes of the mice, has been confirmed. Therefore, each of the lactic acid bacteria strains of Bifidobacterium longum and Lactobacillus rhamnosus exhibits an anti-obesity effect so as to be effectively usable as a food, a drug or a feed for preventing or treating obesity, thereby being very useful in related industries.

IPC Classes  ?

• A61K 35/744 - Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
• A61K 35/745 - Bifidobacteria
• A61K 35/747 - Lactobacilli, e.g. L. acidophilus or L. brevis
• A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
• A23K 10/16 - Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
• A61P 3/04 - AnorexiantsAntiobesity agents

Abstract

Disclosed are a miserite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass. A miserite crystallized glass for an artificial tooth according to the present invention is colored with any one of the shades in groups A, B, C and D of the Vita shade guide which is a tooth shade reference. The miserite crystallized glass has a miserite crystal phase as the main phase and comprises a hydroxyapatite crystal phase and a xonotlite crystal phase as additional phases.

IPC Classes  ?

• C03C 4/02 - Compositions for glass with special properties for coloured glass
• C03C 3/087 - Glass compositions containing silica with 40% to 90% silica by weight containing aluminium oxide or an iron compound containing an oxide of a divalent metal containing calcium oxide, e.g. common sheet or container glass
• C03C 3/095 - Glass compositions containing silica with 40% to 90% silica by weight containing rare earths
• A61C 13/08 - Artificial teethMaking same
• C03C 3/078 - Glass compositions containing silica with 40% to 90% silica by weight containing an oxide of a divalent metal, e.g. an oxide of zinc
• C03C 4/00 - Compositions for glass with special properties
• A61K 6/836 - Glass

Abstract

The present invention relates to an ibuprofen conjugate in which ibuprofen (S-(+)-ibuprofen) is covalently linked to a guanidine-terminal-group-bound sugar alcohol derivative and to a pharmaceutical composition containing the same. The ibuprofen conjugate in which ibuprofen is covalently linked to a guanidine-terminal-group-bound sugar alcohol derivative can more effectively penetrate into the brain by passing through the blood-brain barrier (BBB), thus enabling efficient drug delivery to the brain, whereby administration of the ibuprofen conjugate in an optimal dose can minimize side effects of nonsteroidal anti-inflammatory drugs (NSAIDs) and can prevent or treat degenerative brain disease.

IPC Classes  ?

• A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
• A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
• A61K 49/00 - Preparations for testing in vivo
• A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
• A61P 25/16 - Anti-Parkinson drugs
• A61K 31/155 - Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (HN=C(OH)NH2), isothiourea (HN=C(SH)—NH2)
• A61K 31/16 - Amides, e.g. hydroxamic acids
• A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
• C07D 311/86 - Oxygen atoms, e.g. xanthones

Abstract

Disclosed are a wollastonite crystallized glass for an artificial tooth and a method for coloring same, the method enabling a production of a uniform shade without degrading the physical properties of a crystallized glass by means of simply adding a small amount of coloring additive powder when preparing the crystallized glass.

IPC Classes  ?

• C03C 4/02 - Compositions for glass with special properties for coloured glass
• A61C 13/08 - Artificial teethMaking same
• C03C 4/00 - Compositions for glass with special properties
• A61C 13/083 - Porcelain or ceramic teeth
• C03C 3/112 - Glass compositions containing silica with 40% to 90% silica by weight containing halogen or nitrogen containing fluorine
• A61K 6/836 - Glass
• C03B 32/02 - Thermal crystallisation, e.g. for crystallising glass bodies into glass-ceramic articles
• C03C 10/00 - Devitrified glass ceramics, i.e. glass ceramics having a crystalline phase dispersed in a glassy phase and constituting at least 50% by weight of the total composition
• A61C 19/10 - Supports for artificial teeth for transport or for comparison of the colour

Abstract

A system for analyzing miRNA on the basis of distributed processing comprises: a client device for transmitting target sequence information by pre-processing primitive data analyzed on the basis of next generation sequencing (NGS); a miRNA database containing a miRNA identifier and a sequence of miRNA identified using the identifier; a target gene database containing the miRNA identifier and target gene information matched with the identifier; and an analysis server for extracting matched target miRNA from the miRNA database on the basis of the received target sequence information, and extracting the matched target gene information from the target gene database on the basis of the target miRNA. The target sequence information is selected on the basis of the duplicated number of sequences in NGS analysis data.

IPC Classes  ?

• G16B 40/00 - ICT specially adapted for biostatisticsICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
• G16B 50/00 - ICT programming tools or database systems specially adapted for bioinformatics
• G16B 25/00 - ICT specially adapted for hybridisationICT specially adapted for gene or protein expression

Abstract

The present invention relates to a cell transformation method that enables highly efficient and functional cell transformation by applying sodium phenylbutyrate, tauroursodeoxycholic acid, or butylated hydroxyanisole, which are new regulation factors which can be used to explore cell organelle homeostasis during dedifferentiation and to control stress, during culturing. More particularly, according to the present invention, the addition of at least one selected from the group consisting of sodium phenylbutyrate, tauroursodeoxycholic acid, and butylated hydroxyanisole in the culturing process for cell transformation can not only promote cell transformation induction efficiency, but also dramatically reduces the time required to induce cell transformation. At such time, the sodium phenylbutyrate, tauroursodeoxycholic acid, or butylated hydroxyanisole inhibit ageing induction and oxidization stress that occur during the cell transformation induction process, and induces a cell proliferation and mitochondrial activity promotion effect, thereby effectively improving cell transformation inducing culture conditions.

IPC Classes  ?

• C12N 5/0735 - Embryonic stem cellsEmbryonic germ cells
• C12N 5/074 - Adult stem cells
• C12N 5/071 - Vertebrate cells or tissues, e.g. human cells or tissues

Abstract

Disclosed are a data management method and system based on proxy re-encryption in an IoT lightweight terminal environment. The data management method based on proxy re-encryption in an IoT lightweight terminal environment, according to one aspect of the present invention, provides a terminal management method on the basis of a proxy re-encryption method, and thus only a reliable user can decrypt received data by using the user's private key in a step of managing a re-encryption key. In addition, compared with a conventional inter-terminal encryption communication method, the present invention can use re-encryption so as to reduce communication frequency, which increases in a data encryption transmission process.

IPC Classes  ?

• H04L 9/08 - Key distribution
• H04L 29/06 - Communication control; Communication processing characterised by a protocol
• H04L 9/06 - Arrangements for secret or secure communicationsNetwork security protocols the encryption apparatus using shift registers or memories for blockwise coding, e.g. D.E.S. systems

Abstract

The present invention relates to a phase shifter for generating a difference in phase between a first transmission path and a second transmission path, the phase shifter comprising: a phase delay circuit unit which forms the first transmission path and includes a transmission line having a predetermined electrical length; and a phase control circuit unit which forms the second transmission path and includes at least one resonant circuit capable of adjusting a phase gradient according to the phase gradient of the phase delay circuit unit.

IPC Classes  ?

• H03H 9/66 - Phase shifters
• H03H 17/08 - Networks for phase-shifting
• H03H 7/01 - Frequency selective two-port networks

Abstract

A KSI-based authentication and communication method for a safe smart home environment, and a system therefor are disclosed. The KSI-based authentication and communication method for a safe smart home environment in a system comprising a user terminal, a KSI server, and an IoT device for communicating with the KSI server and the user terminal through a gateway, according to one aspect of the present invention, comprises the steps in which the IoT device: registers, in advance, identity information by encrypting the identity information with a secret group key, distributed in advance, for continuous communication with the gateway, the user terminal, and the KSI server; performs mutual authentication by using the secret group key shared in advance; and performs confidential communication.

IPC Classes  ?

• H04L 9/08 - Key distribution
• H04L 9/32 - Arrangements for secret or secure communicationsNetwork security protocols including means for verifying the identity or authority of a user of the system
• H04L 12/28 - Data switching networks characterised by path configuration, e.g. LAN [Local Area Networks] or WAN [Wide Area Networks]
• H04L 9/06 - Arrangements for secret or secure communicationsNetwork security protocols the encryption apparatus using shift registers or memories for blockwise coding, e.g. D.E.S. systems

Abstract

The present invention relates to a Doherty combiner used in a Doherty power amplifier, the Doherty combiner comprising: a phase shift section connected to one end of a carrier amplifier so as to change a phase of an RF signal output from the carrier amplifier; a matching section connected to an output terminal of the Doherty power amplifier so as to impedance-match an output of the Doherty power amplifier; and a bandwidth improvement section connected to one end of a peaking amplifier so as to change at least one of a phase bandwidth and an amplitude bandwidth of the Doherty power amplifier.

IPC Classes  ?

• H03F 1/02 - Modifications of amplifiers to raise the efficiency, e.g. gliding Class A stages, use of an auxiliary oscillation
• H03F 1/42 - Modifications of amplifiers to extend the bandwidth
• H03F 1/56 - Modifications of input or output impedances, not otherwise provided for
• H03F 3/21 - Power amplifiers, e.g. Class B amplifiers, Class C amplifiers with semiconductor devices only
• H03F 3/60 - Amplifiers in which coupling networks have distributed constants, e.g. with waveguide resonators

Abstract

The present invention relates to an automatic power cutoff multi-tap system and method and, more specifically, to an automatic power cutoff multi-tap system and an automatic multi-tap power cutoff method which: determine whether a user is asleep by using an Internet of thing (IoT) terminal making contact with a user body so as to detect biometric information; and cut off output power of a wirelessly connected smart multi-tap when the user is asleep.

IPC Classes  ?

• H01R 13/70 - Structural association with built-in electrical component with built-in switch
• H01R 25/00 - Coupling parts adapted for simultaneous co-operation with two or more identical counterparts, e.g. for distributing energy to two or more circuits
• H01R 13/10 - Sockets for co-operation with pins or blades
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons

Abstract

2/PCL coating layer controls corrosion degradation of conventional orthopedic Mg alloys and exhibits excellent biocompatibility, thus being useful as an implant for fixing bones.

IPC Classes  ?

• C23C 30/00 - Coating with metallic material characterised only by the composition of the metallic material, i.e. not characterised by the coating process
• C23C 8/42 - Solid state diffusion of only non-metal elements into metallic material surfacesChemical surface treatment of metallic material by reaction of the surface with a reactive gas, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using liquids, e.g. salt baths, liquid suspensions only one element being applied
• A61L 27/30 - Inorganic materials
• A61L 27/34 - Macromolecular materials
• A61L 27/04 - Metals or alloys
• C23C 28/00 - Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of main groups , or by combinations of methods provided for in subclasses and
• A61L 27/58 - Materials at least partially resorbable by the body
• C22C 23/04 - Alloys based on magnesium with zinc or cadmium as the next major constituent
• C23C 8/02 - Pretreatment of the material to be coated

Abstract

The present invention provides a method for preparing an injectable thermosensitive chitosan/TEMPO-oxidized cellulose nanofibers hydrogel. The injectable thermosensitive chitosan/TEMPO-oxidized cellulose nanofibers hydrogel exhibits superior biocompatibility through addition of TEMPO-oxidized cellulose nanofibers, and excellent cell proliferation and bone regeneration through cellular interaction, and is gelled in vivo, thus being highly useful as a filler for wound healing and bone regeneration. In addition, the injectable thermosensitive chitosan/TEMPO-oxidized cellulose nanofibers hydrogel exhibits excellent porosity, has an interconnected structure and is thermogelling, based on thermosensitivity of undergoing a sol-gel transition depending on temperature, thus inducing rapid gelation in vivo and facilitating bone regeneration upon implantation in vivo.

IPC Classes  ?

• A61L 27/26 - Mixtures of macromolecular materials
• A61L 27/52 - Hydrogels or hydrocolloids
• A61L 27/20 - Polysaccharides
• A61L 27/50 - Materials characterised by their function or physical properties
• A61L 27/54 - Biologically active materials, e.g. therapeutic substances
• A61L 27/58 - Materials at least partially resorbable by the body

Abstract

The present invention provides a method for preparing an injectable thermosensitive hydrogel for preventing adhesion including mixing methyl cellulose, polyethylene glycol, oxidized cellulose nanofibers and carboxymethyl cellulose. The injectable thermosensitive hydrogel for preventing adhesion is a sol at a low temperature and induces rapid gelation upon in vivo implantation due to thermosensitivity. In addition, the hydrogel can be rapidly changed into physical hydrogel without separate additives or chemical reaction during in vivo condition. In addition, the injectable thermosensitive hydrogel for preventing adhesion exhibits excellent biodegradability and biocompatibility, has no cytotoxicity, inhibits in vitro migration of rat bone marrow mesenchymal stem cells (rBMSCs), and exhibits anti-adhesion efficacy in a rat model of sidewall defect-cecum abrasion in vivo, thus being useful as an effective anti-adhesive agent.

IPC Classes  ?

• A61L 31/14 - Materials characterised by their function or physical properties
• A61L 31/12 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material
• A61L 31/04 - Macromolecular materials
• A61L 31/06 - Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Abstract

The present invention provides a device and method for analyzing a gait by using an acceleration sensor worn on an ankle. A device for analyzing a gait by using an acceleration sensor worn on an ankle according to an aspect of the present invention comprises: a reception unit for receiving a signal according to the gait of a patient from an acceleration sensor included in a band worn on the ankle of the patient; and an analysis unit for preprocessing the received signal according to the gait of the patient, extracting features from the preprocessed signal, and calculating the energy of the gait and the correlation coefficient for characteristics of the gait by using the extracted features, so as to analyze the gait of the patient.

IPC Classes  ?

• A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
• A61B 5/00 - Measuring for diagnostic purposes Identification of persons

Abstract

The present invention relates to a nystagmus video test device and method and, more specifically, to a nystagmus video test device and method using an infrared camera, the device and the method rotating a patient to the left and right so as to influence a vestibular organ of the patient, and analyzing, on the basis of the rotation condition of the patient, an infrared pupil image captured by the infrared camera, so as to perform a nystagmus test on the patient.

IPC Classes  ?

• A61B 5/00 - Measuring for diagnostic purposes Identification of persons
• A61B 3/113 - Objective types, i.e. instruments for examining the eyes independent of the patients perceptions or reactions for determining or recording eye movement
• G06K 9/00 - Methods or arrangements for reading or recognising printed or written characters or for recognising patterns, e.g. fingerprints